Welcome back, today is Tuesday, October twenty-seventh, and we begin in India, which Indian Television Dot Com reports was a standout market inside L'Oréal's fastest-growing region, South Asia, Pacific, Middle East, North Africa and sub-Saharan Africa. Adjusted like-for-like sales across L'Oréal's South Asia, Pacific, Middle East and Africa region rose fifteen point eight percent over the nine months, with growth accelerating further in India and Indonesia in the third quarter, led by haircare and skincare, per Indian Television Dot Com. That same account puts e-commerce up about seventeen percent, ahead of the online market, with all four divisions and all five regions in growth. Following our earlier report on the nine-month results, the company has completed its acquisition of a majority stake in Innovist, a digital-first Indian personal care group. Its corporate venture arm BOLD and the retailer Nykaa separately announced a partnership to take minority stakes in Indian beauty, personal care and wellness brands. The category's largest player is buying into that market rather than building in it, which sets the entry template rivals get read against. Industry reaction leans toward uneven strength, with the professionally endorsed salon and dermatological lines outpacing the mass consumer business. Separately, Brussels has moved on the reformulation clock. The European Parliament has approved legislation giving cosmetics manufacturers more flexible deadlines to withdraw products containing substances classified as carcinogenic, mutagenic or toxic to reproduction, according to Global Cosmetics News. That reporting places the measure inside the EU's Omnibus Six chemistry reforms. The final text and the dates on which it applies have not been published, and those dates are what decide whether a reclassification costs a brand a reformulation or a write-off. A recurring compliance concern is timing rather than the substance list itself, with some practitioners reading new CMR entries as biting from the moment product reaches the EU market, and smaller brands skeptical that simplification at EU level changes much against national registration and marketplace checks. Staying with the numbers, Galderma has raised its full-year twenty twenty-six sales guidance, the second consecutive quarter it has done so, per Global Cosmetics News. That account ties the raise to revenue growth across the Swiss company's therapeutic dermatology, injectable aesthetics and skincare businesses, and does not carry the revised figure. Clean reads on whether injectable and dermatological skincare demand is still expanding are scarce, which is why a pure-play raise carries weight against the mass-market prints. Industry reaction leans toward portfolio breadth rather than one hit, with a recurring observation that the growth is landing while a headline injectable launch still waits on outstanding US regulatory items, which some read as upside not yet in the numbers. In distribution, Kayali has entered China through a single retailer. The Dubai-based fragrance brand founded by Mona Kattan debuted exclusively with Sephora, pairing a rollout across more than three hundred stores with a founder-led push, per WWD. Cosmetics Business dates the omnichannel debut to the fifteenth of October, across those stores and Sephora's digital platforms, and reports the brand is aiming to rank among Sephora China's top three fragrance names. A one-partner entry concentrates the bet, buying scale and sell-in speed at the cost of any demand read outside that footprint. Some market-watchers place the move in a wider shift, reading a retail exclusive as the lower-friction way into China as cross-border e-commerce enters a stricter compliance phase, while a recurring thread in consumer discussion is doubt about the scents' longevity on skin. Now, a few more headlines moving the trade today. Ben Bennett's incubator The Center has partnered with the dermatologist Mamina Turegano to acquire and relaunch the skincare brand Boscia, per WWD. BASF has reportedly raised its takeover offer for Evonik Industries to more than eleven billion euros, Global Cosmetics News reports, citing consolidation pressure across European speciality chemicals. And finally, Myntra's own platform data puts half of its Gen Z beauty buyers in India's Tier two and Tier three cities, with Korean beauty demand up two hundred percent year on year.